Inovio sinks 26% after US government decides to discontinue funding for next phase of COVID-19 vaccine trial | Markets Insider

Generating your feed, please be patient ...

Inovio sinks 26% after US government decides to discontinue funding for next phase of COVID-19 vaccine trial | Markets Insider | Zootzle